| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10220226 | Gynecologic Oncology | 2018 | 6 Pages |
Abstract
Women with MMR-deficient endometrial cancers who receive adjuvant therapy have a lower rate of recurrence compared to those with MMR-proficient cancers. However, on multivariable analysis, MMR status does not remain associated with differences in PFS or OS.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Soyoun Rachel Kim, Annick Pina, Arianne Albert, Jessica McAlpine, Robert Wolber, C. Blake Gilks, Janice S. Kwon,